Clozapine oral formulations - Jazz Pharmaceuticals

Drug Profile

Clozapine oral formulations - Jazz Pharmaceuticals

Alternative Names: clozapine ODT; clozapine once-daily; Clozapine QD; FazaClo HD; FazaClo LD; FazaClo ODT; Versacloz

Latest Information Update: 10 Sep 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Alamo Pharmaceuticals; Alkermes plc; Douglas Pharmaceuticals
  • Developer Azur Pharma; Jazz Pharmaceuticals plc
  • Class Antipsychotics; Dibenzazepines
  • Mechanism of Action Dopamine D2 receptor antagonists; GABA receptor antagonists; Muscarinic receptor antagonists; Serotonin 2A receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Marketed Schizophrenia

Most Recent Events

  • 11 Feb 2014 Launched for Schizophrenia (treatment-resistant) in USA (PO, Suspension)
  • 30 May 2013 Biomarkers information updated
  • 20 Mar 2013 Clozapine controlled release is still in development for Schizoprenia in Ireland
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top